Reactivation of latent herpes viruses in astronauts

Psychoneuroimmunology, Two-Volume Set

Volumn 2, Issue , 2007, Pages 851-868

  Pierson, Duane L ^a   Mehta, Satish K ^a   Stowe, Raymond P ^b  

^a NASA JOHNSON SPACE CENTER   (United States)

^b Microgen Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46149098546     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50047-2     Document Type: Chapter

References (126)

1. Abendroth A., Arvin A.M. Host response to primary infection 2000, Cambridge University Press, New York.
2. Arvin A.M., Gershon A.A. Live attenuated varicella vaccine. Annu. Rev. Microbiol. 1996, 50:59-100.
3. Arvin A.M., Koropchak C.M., Wittek A.E. Immunologic evidence of reinfection with varicella-zoster virus. Journal of Infectious Diseases 1983, 148:200-205.
4. Asano Y., Nakayama H., Yazaki T., Kato R., Hirose S. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 1977, 59:3-7.
5. Balraj V., John T.J. An epidemic of varicella in rural southern India. Journal of Tropical Medicine and Hygiene 1994, 97:113-116.
6. Brandwein M., Nuovo G., Ramer M., Orlowski W., Miller L. Epstein-Barr virus reactivation in hairy leukoplakia. Mod. Pathol. 1996, 9:298-303.
7. Cacioppo J.T., Kiecolt-Glaser J.K., Malarkey W.B., Laskowski B.F., Rozlog L.A., Poehlmann K.M., Burleson M.H., Glaser R. Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus. Horm. Behav 2002, 42:32-41.
8. Caillot-Augusseau A., Lafage-Proust M.-H., Soler C., Pernod J., Dubois F., Alexandre C. Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95). Clin. Chem. 1998, 44:578-585.
9. Carney W.P. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. J. Infect. Dis. 1981, 144:47-54.
10. Castro V.A., Thrasher A.N., Healy M., Ott C.M., Pierson D.L. Microbial characterization during the early habitation of the International Space Station. Microb. Ecol. 2004, 47:119-126.
11. Cohen J.I. Epstein-Barr virus infection. New England Journal of Medicine 2000, 343:481-492.
12. Crucian B.E. Altered cytokine production by specific human peripheral blood cell subsets immediately following space flight. J. Interferon Cytokine Res. 2000, 20:547-556.
13. Crucian B.E., Stowe R.P., Pierson D.L., Sams C.F. Routine detection of Epstein-Barr virus specific T-cells in the peripheral blood by flow cytometry. J. Immunol. Methods 2001, 247:35-47.
14. Daynes R.A., Araneo B.A., Hennebold J., Enioutina E., Mu H.H. Steroids as regulators of the mammalian immune response. Endogenous Immune Regulators 1995, 105:14S-19S.
15. Del Prete G. The concept of type-1 and type-2 helper T cells and their cytokines in humans. International Reviews of Immunology 1998, 16:427-455.
16. De Martino M., Rossi M., Azzari C., Chiarelli F., Galli L., Vierucci A. Low IgG3 and high IgG4 subclass levels in children with advanced human immunodeficiency virus-type 1 infection and elevated IgE levels. Annals of Allergy, Asthma, and Immunology 1999, 83:160-164.
17. De Martino M., Rossi M., Azzari C., Chiarelli F., Galli L., Vierucci A. Interleukin-6 synthesis and IgE overproduction in children with perinatal human immunodeficiency virustype 1 infection. Annals of Allergy, Asthma, and Immunology 1999, 82:212-216.
18. Dobbs C.M., Vasquez M., Glaser R., Sheridan J.F. Mechanisms of stress-induced modulation of viral pathogenesis and immunity. J. Neuroimmunol. 1993, 48:151-160.
19. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proceedings of the Association of American Physicians 1996, 108:374-381.
20. Ferrandez M.D., Maynar M., De la Fuente M. Effects of a long-term training program of increasing intensity on the immune function of indoor Olympic cyclists. International Journal of Sports Medicine 1996, 17:592-596.
21. Fiala M. Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J. Infect. Dis. 1975, 132:421-433.
22. Fleshner M., Deak T., Spencer R.L., Laudenslager M.L., Watkins L.R., Maier S.F. A long term increase in basal levels of corticosterone and a decrease in corticotrophin-binding globulin following acute stressor exposure. Endocrinology 1995, 136:5336-5342.
23. Forghani B. Varicella-zoster virus antibodies. Methods of enzymatic analysis 1986, vol. 10:267-284. Verlag Chemie, Weinheim, Germany. 3rd ed. H. Bergmeyer (Ed.).
24. Forghani B. Laboratory diagnosis of varicella-zoster virus infection. Varicellazoster virus: virology and clinical management 2000, 351-382. Cambridge University Press, New York. A. M. Arvin, A. A. Gershon (Eds.).
25. Furuta Y., Ohtani F., Fukuda S., Inuyama Y., Nagashima K. Reactivation of varicella-zoster virus in delayed facial palsy after dental treatment and oro-facial surgery. J. Med. Virol. 2000, 62:42-45.
26. Gauquelin G., Geelen G., Gharib C., Grigoriev A., Guell A., Kvetnansky R., Macho L., Noskov V., Pasi P., Soukanov J., Patricot M., Raffin J., Wang X.G., Poliakov V., Chretien J.L. Volume regulating hormones, fluid and electrolyte modifications during the Aragatz mission (MIR station). Proceedings of the Fourth European Symposium on Life Sciences Research in Space 1990, 603-608. held in, ESA SP- 307 ed., European Space Agency, Paris.
27. Gazenko O.G., Schulzhenko E.B., Grigoriev A.I., Atkov O., Egorov A.D. Review of basic medical results of the Salyut-7-Soyuz-T 8-month manned flight. Acta Astronaut. 1988, 17:155-160.
28. Gershon A.A., LaRussa P., Hardy I., Steinberg S., Silverstein S. Varicella vaccine: the American experience. Journal of Infectious Diseases 1992, 166(Suppl 1):S63-S68.
29. Gershon A.A., Steinberg S.P. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicel. Journal of Infectious Diseases 1990, 161:661-666.
30. Gershon A.A., Steinberg S.P., Gelb L. Clinical reinfection with varicella-zoster virus. Journal of Infectious Diseases 1984, 149:137-142.
31. Gershon A.A., Steinberg S.P., LaRussa P., Ferrara A., Hammerschlag M., Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. Journal of Infectious Diseases 1988, 158:132-137.
32. Gilden D.H., Kleinschmidt-DeMasters B.K., LaGuardia J.J., Mahalingam R., Cohrs R.J. Neurologic complications of the reactivation of varicella-zoster virus. New England Journal of Medicine 2000, 342:635-645.
33. Glaser R., Kiecolt-Glaser J.K. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am. J. Med. 1998, 105:35S-42S.
34. Glaser R., Kiecolt-Glaser J.K., Speicher C.E., Holliday J.E. Stress, loneliness, and changes in herpesvirus latency. J. Behav. Med. 1985, 8:249-260.
35. Glaser R., Kiecolt-Glaser J.K., Stout J.C., Tarr K.L., Speicher C.E., Holliday J.E. Stress-related impairments in cellular immunity. Psychiatry Research 1985, 16:233-239.
36. Glaser R., Kutz L.A., MacCallum R.C., Malarkey W.B. Hormonal modulation of Epstein-Barr virus replication. Neuroendocrinology 1995, 62:356-361.
37. Glaser R., Pearl D.K., Kiecolt-Glaser J.K., Malarkey W.B. Plasma cortisol levels and reactivation of latent Epstein-Barr virus in response to examination stress. Psychoneuroendocrinology 1994, 19:765-772.
38. Glaser R., Pearson G.R., Bonneau R.H., Esterling B.A., Atkinson C., Kiecolt-Glaser J.K. Stress and the memory T-cell response to the Epstein-Barr virus in healthy medical students. Health Psychology 1993, 12:435-442.
39. Glaser R., Pearson G.R., Jones J.F., Hillhouse J., Kennedy S., Mao H.Y., Kiecolt-Glaser J.K. Stress-related activation of Epstein-Barr virus. Brain, Behavior and Immunity 1991, 5:219-232.
40. Glaser R., Rice J., Sheridan J., Fertel R., Stout J., Speicher C., Pinsky D., Kotur M., Post A., Beck M., et al. Stressrelated immune suppression: health implications. Brain, Behavior and Immunity 1987, 1:7-20.
41. Graebe A., Schuck E.L., Lensing P., Putcha L., Derendorf H. Physiological, pharmacokinetic, and pharmacodynamic changes in space. Journal of Clinical Pharmacology 2004, 44:837-853.
42. Granger D.A., Schwartz E.B., Booth A., Curran M., Zakaria D. Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adults. Psychoneuroendocrinology 1999, 24:567-579.
43. Grigoriev A.I., Polyakov V.V., Bogomolov V.V., Egorov A.D., Pestov I.D., Kozlovskaya I.B. Medical results of the fourth prime expedition on the orbital station Mir. Proceedings of the Fourth European Symposium on Life Sciences Research in Space 1990, 19-22. European Space Agency, Paris. ESA SP-307 ed.
44. Henle W., Henle G. Epstein-Barr virus and human malignancies. Cancer 1974, 43:1368-1374.
45. Jerant A.F., DeGaetano J.S., Epperly T.D., Hannapel A.C., Miller D.R., Lloyd A.J. Varicella susceptibility and vaccination strategies in young adults. Journal of the American Board of Family Practice 1998, 11:296-306.
46. Jordan M.C. Infectious mononucleosis due to Epstein-Barr virus and cytomegalovirus. Infectious diseases and medical microbiology 1986, 1311. W. B. Saunders Company, Philadelphia. A. I. Braude, C. E. Davis, J. Fierer (Eds.).
47. Kameyama T., Sujaku C., Yamamoto S., Hwang C.B., Shillitoe E.J. Shedding of herpes simplex virus type 1 into saliva. J. Oral Pathol. 1988, 17:478-481.
48. Kaur I., Simons E.R., Castro V.A., Ott C.M., Pierson D.L. Changes in neutrophil functions in astronauts. Brain, Behavior and Immunity 2004, 18:443-450.
49. Kaur I., Simons E.R., Castro V.A., Ott C.M., Pierson D.L. Changes in monocyte functions of astronauts. Brain, Behavior and Immunity 2005, 547-554.
50. Kiecolt-Glaser J.K., Malarkey W.B., Chee M., Newton T., Cacioppo J.T., Mao H.Y., Glaser R. Negative behavior during marital conflict is associated with immunological down-regulation [see comments]. Psychosom. Med. 1993, 55:395-409.
51. Kiecolt-Glaser J.K., Newton T., Cacioppo J.T., MacCallum R.C., Glaser R., Malarkey W.B. Marital conflict and endocrine function: are men really more physiologically affected than women?. Journal of Consulting and Clinical Psychology 1996, 64:324-332.
52. Kimura H., Morita M., Yabuta Y., Kuzushima K., Kato K., Kojima S., Matsuyama T., Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 1999, 37:132-136.
53. Kimzey S.L. Hematology and immunology studies. Biomedical results from Skylab 1977, 249-282. NASA SP-377 ed., National Aeronautics and Space Administration, Washington, DC. R. S. Johnston, L. F. Dietlein (Eds.).
54. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 1989, 22:150-169.
55. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research-recent developments and applications. Psychoneuroendocrinology 1994, 19:313-333.
56. Konstantinova I.V., Rykova M.P., Lesnyak A.T., Antropova E.A. Immune changes during long-duration missions. J. Leukoc. Biol. 1993, 54:189-201.
57. Koskiniemi M., Rantalaiho T., Piiparinen H., von Bonsdorff C.H., Farkkila M., Jarvinen A., Kinnunen E., Koskiniemi S., Mannonen L., Muttilainen M., Linnavuori K., Porras J., Puolakkainen M., Raiha K., Salonen E.M., Ukkonen P., Vaheri A., Valtonen V. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J. Neurovirol. 2001, 7:400-408.
58. Krause P.R., Klinman D.M. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat. Med. 2000, 6:451-454.
59. Kusunoki Y., Huang H., Fukuda Y., Ozaki K., Saito M., Hirai Y., Akiyama M. A positive correlation between the precursor frequency of cytotoxic lymphocytes to autologous Epstein-Barr virus-transformed B cells and antibody titer level. Microbiol. Immunol. 1993, 37:461-469.
60. LaRussa P., Steinberg S.P., Shapiro E., Vazquez M., Gershon A.A. Viral strain identification in varicella vaccinees with disseminated rashes. Pediatric Infectious Disease Journal 2000, 19:1037-1039.
61. Lathey J.L., Spector S.A. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 1991, 65:6371-6375.
62. Laudenslager, M. L., Bettinger, T., and Sackett, G. (In press). Saliva as a medium for assessing cortisol and other compound in nonhuman primates: collection,.
63. Leach C.S. Fluid control mechanisms in weightlessness. Aviat., Space Environ. Med. 1987, 58:A74-A79.
64. Leach C.S. Biochemical and hematologic changes after short-term space flight. Microgravity Quarterly 1992, 2:69-75.
65. Leach C.S., Alexander W.C., Johnson P.C. Endocrine, electrolyte, and fluid volume changes associated with Apollo missions. Biomedical results of Apollo 1975, 163-184. NASA SP-368, National Aeronautics and Space Administration, Washington, DC. R. S. Johnston, L. F. Dietlein, C. A. Berry (Eds.).
66. Leach C.S., Alfrey C.P., Suki W.N., Leonard J.I., Rambaut P.C., Inners L.D., Smith S.M., Lane H.W., Krauhs J.M. Regulation of body fluid comPARTments during short-term space- flight. J. Appl. Physiol. 1996, 81:105-116.
67. Leach C.S., Chen J.P., Crosby W., Johnson P.C., Lange R.D., Larkin E., Tavassoli M. Hematology and biochemical findings of Spacelab 1 flight. Regulation of erythropoiesis 1988, 415-453. PMA Publishing Corp, New York. E. D. Zanjani, M. Tavassoli, J. L. Ascensao (Eds.).
68. Leach C.S., Rambaut P.C. Biochemical responses of the Skylab crewmen: an overview. Biomedical results from Skylab 1977, 204-216. NASA SP-377, National Aeronautics and Space Administration, Washington, DC. R. S. Johnston, L. F. Dietlein (Eds.).
69. Leach Huntoon C.S., Cintron N.M. Endocrine system and fluid and electrolyte balance. Humans in spaceflight 1996, vol. III:89-104. book 1, American Institute of Aeronautics and Astronautics, Reston, VA. C. S. Leach Huntoon, V. V. Antipov, A. I. Grigoriev (Eds.).
70. Lennette E.T. Epstein Barr virus. Manual of clinical microbiology 1991, 847-852. American Society for Microbiology, Washington, DC. A. Balows, W. J. Hausler, K. L. Herrmann, H. D. Isenberg, H. J. Shadomy (Eds.).
71. Levin M.J., Smith J.G., Kaufhold R.M., Barber D., Hayward A.R., Chan C.Y., Chan I., Li D.J.J.S.F., Wang W., Keller P.M., Shaw A., Silber J.L., Schleinger K., Chalikonda I., Vessey S.J.R., Caulfield M.J. Decline in varicella-zoster virus (VZV) -specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J. Infect. Dis. 2003, 188:1336-1344.
72. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc. Natl. Acad. Sci. USA 1998, 95:12544-12549.
73. Lucey D.R. Evolution of the type-1 (Th1)-type-2 (Th2) cytokine paradigm. Infectious Disease Clinics of North America 1999, 13:1-9.
74. Malarkey W.B., Kiecolt-Glaser J.K., Pearl D., Glaser R. Hostile behavior during marital conflict alters pituitary and adrenal hormones. Psychosom. Med. 1994, 56:41-51.
75. McDade T.W., Stallings J.F., Angold A., Costello E.J., Burleson M., Cacioppo J.T., Glaser R., Worthman C.M. Epstein-Barr virus antibodies in whole blood spots: a minimally invasive method for assessing an aspect of cell-mediated immunity. Psychosom. Med. 2000, 62:560-567.
76. Meehan R., Whitson P., Sams C. The role of psychoneuroendocrine factors on spaceflight-induced immunological alterations. J. Leukocyte Biol. 1993, 54:236-244.
77. Mehta S.K., Cohrs R.J., Forghani B., Zerbe G., Gilden D.H., Pierson D.L. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J. Med. Virol. 2004, 72:174-179.
78. Mehta S.K., Kaur I., Grimm E.A., Smid C., Feeback D.L., Pierson D.L. Decreased non-MHC-restricted (CD56+) killer cell cytotoxicity after spaceflight. J. Appl. Physiol. 2001, 91:1814-1818.
79. Mehta S.K., Pierson D.L., Cooley H., Dubow R., Lugg D. Epstein-Barr virus reactivation associated with diminished cell-mediated immunity in Antarctic expeditioners. J. Med. Virol. 2000, 61:235-240.
80. Mehta S.K., Stowe R.P., Feiveson A.H., Tyring S.K., Pierson D.L. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. Journal of Infectious Diseases 2000, 182:1761-1764.
81. Mills P.J., Meck J.V., Waters W.W., D'Aunno D., Zeigler M.G. Peripheral leukocyte subpopulations and catecholamine levels in astronauts as a function of mission duration. Psychosom. Med. 2001, 63:886-890.
82. Morel P.A., Oriss T.B. Cross regulation between Th1 and Th2 cells. Critical Reviews in Immunology 1998, 18:275-303.
83. Morley J.E., Kay N.E., Solomon G.F., Plotnikoff N.P. Neuropeptides: conductors of the immune orchestra. Life Sci. 1987, 41:527-544.
84. Muller H.K., Lugg D.J., Quinn D. Cell mediated immunity in Antarctic wintering personnel; 1984-1992. Immunol. Cell Biol. 1995, 73:316-320.
85. Muller H.K., Lugg D.J., Ursin H., Quinn D., Donovan K. Immune responses during an Antarctic summer. Pathology 1995, 27:186-190.
86. Niedobitek G., Agathanggelou A., Herbst H., Whitehead L., Wright D.H., Young L.S. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J. Pathol. 1997, 182:151-159.
87. Oxman M.N. Herpes stomatitis. Infectious diseases and medical microbiology 1986, 752-769. W. B. Saunders Company, Philadelphia. A. I. Braude, C. E. Davis, J. Fierer (Eds.).
88. Payne D.A., Mehta S.K., Tyring S.K., Stowe R.P., Pierson D.L. Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. Aviat., Space Environ. Med. 1999, 70:1211-1213.
89. Pierson D.L. Microbial contamination of spacecraft. Gravit. Space Biol. Bull. 2001, 14:1-6.
90. Pierson D.L., Stowe R.P., Phillips T.M., Lugg D.J., Mehta S.K. Epstein-Barr virus shedding by astronauts during space flight. Brain, Behavior and Immunity 2005, 19:235-242.
91. Preiksaitis J.K., Diaz-Mitoma F., Mirzayans F., Roberts S., Tyrrell D.L. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic respon. J. Infect. Dis. 1992, 166:986-994.
92. Ramirez F., Fowell D.J., Puklavec M., Simmonds S., Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J. Immunol. 1996, 156:2406-2412.
93. Rand K.H., Hoon E.F., Massey J.K., Johnson J.H. Daily stress and recurrence of genital herpes simplex. Arch. Intern. Med. 1990, 150:1889-1893.
94. Rantalaiho T., Farkkila M., Vaheri A., Koskiniemi M. Acute encephalitis from 1967 to 1991. Journal of the Neurological Sciences 2001, 184:169-177.
95. Rawson H., Crampin A., Noah N. Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data. Br. Med. J. 2001, 323:1091-1093.
96. Rice G.P.A., Schrier R.D., Oldstone M.B.A. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA 1984, 81:6134-6138.
97. Rook G.A., Hernandez-Pando R., Lightman S.L. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunology Today 1994, 15:301-303.
98. Schunemann S., Mainka C., Wolff M.H. Subclinical reactivation of varicella-zoster virus in immunocompromised and immunocompetent individuals. Intervirology 1998, 41:98-102.
99. Simmons P., Kaushansky K., Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc. Natl. Acad. Sci. USA 1990, 87:1386-1390.
100. Simon M.W. Manifestations of relapsing Epstein-Barr virus illness. Journal of the Kentucky Medical Association 1997, 95:240-243.
101. Smith S.M., Krauhs J.M., Leach C.S. Regulation of body fluid volume and electrolyte concentrations in spaceflight. Adv. Space Biol. Med. 1997, 6:123-165.
102. Smith S.M., Zwart S.R., Block G., Rice B.L., Davis-Street J.E. The nutritional status of astronauts is altered after long-term space flight aboard the International Space Station. Journal of Nutrition 2005, 135:437-443.
103. Smyth J.M., Ockenfels M.C., Gorin A.A., Catley D., Porter L.S., Kirschbaum C., Hellhammer D.H., Stone A.A. Individual differences in the diurnal cycle of cortisol. Psychoneuroendocrinology 1997, 22:89-105.
104. Sonnenfeld G., Taylor G.R., Kinney K.S. Acute and chronic effects of space flight on immune functions. Psychoneuroimmunology 2001, vol. 2:279-289. Academic Press, San Diego. 3rd ed. R. Ader, D. L. Felten, N. Cohen (Eds.).
105. Stagno S., Reynolds D.W., Tsiantos A., Fuccillo D.A., Long W., Alford C.A. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. Journal of Infectious Diseases 1975, 132:568-577.
106. Stein T.P., Leskiw M.J., Schluter M.D. Diet and nitrogen metabolism during spaceflight on the shuttle. J. Appl. Physiol. 1996, 81:82-97.
107. Stein T.P., Leskiw M.J., Schluter M.D., Donaldson M.R., Larina I. Protein kinetics during and after longduration spaceflight on Mir. Am. J. Physiol. 1999, 276:E1014-E1021.
108. Stowe R.P., Mehta S.K., Ferrando A.A., Feeback D.L., Pierson D.L. Immune responses and latent herpesvirus reactivation in spaceflight. Aviat., Space Environ. Med. 2001, 72:884-891.
109. Stowe R.P., Pierson D.L., Barrett A.D.T. Elevated stress hormone levels relate to Epstein-Barr virus reactivation in astronauts. Psychosom. Med. 2001, 63:891-895.
110. Stowe R.P., Pierson D.L., Feeback D.L., Barrett A.D. Stress-induced reactivation of Epstein-Barr virus in astronauts. Neuroimmunomodulation 2000, 8:51-58.
111. Stowe R.P., Sams C.F., Mehta S.K., Kaur I., Jones M.L., Feeback D.L., Pierson D.L. Leukocyte subsets and neutrophil function after short-term spaceflight. J. Leukocyte Biol. 1999, 65:179-186.
112. Stowe R.P., Sams C.F., Pierson D.L. Effects of mission duration on neuroimmune responses in astronauts. Aviat., Space Environ. Med. 2003, 74:1281-1284.
113. Takayama N., Minamitani M., Takayama M. High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain). Acta Paediatrica Japonica 1997, 39:663-668.
114. Tanaka J., Ogura T., Kamiya S., Sato H., Yoshie T., Ogura H., Hatano M. Enhanced replication of human cytomegalovirus in human fibroblasts treated with dexamethasone. J. Gen. Virol. 1984, 65:1759-1767.
115. Tanaka J., Ogura T., Kamiya S., Yoshie T., Yabuki Y., Hatano M. Dexamethasone enhances human cytomegalovirus replication in human epithelial cell cultures. Virology 1984, 136:448-452.
116. Taylor G.R., Janney R.P. In vivo testing confirms a blunting of the human cell-mediated immune mechanism during space flight. J. Leukocyte Biol. 1992, 51:129-132.
117. Taylor G.R., Konstantinova I., Sonnenfeld G., Jennings R. Changes in the immune system during and after space-flight. Adv. Space Biol. Med. 1997, 6:1-32.
118. Tosato G., Steinberg A.D., Yarchoan R., Heilman C.A., Pike S.E., De Seau V., Blaese R.M. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J. Clin. Invest. 1984, 73:1789-1795.
119. Trannoy E., Berger R., Hollander G., Bailleux F., Heimendinger P., Vuillier D., Creusvaux H. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine 2000, 18:1700-1706.
120. Vorobyev Y.I., Gazenko O.G., Shulzhenko Y.B., Grigoryev A.I., Barer A.S., Yegorov A.D., Skiba I.A. Preliminary results of medical investigations during 5-month spaceflight aboard Salyut-7-Soyuz-T orbital complex. Kosmicheskaya Biologiya i Aviakosmicheskaya Meditsina 1986, 20:27-34.
121. Wasik T.J., Jagodzinski P.P., Hyjek E.M., Wustner J., Trinchieri G., Lischner H.W., Kozbor D. Diminished HIVspecific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. Journal of Immunology 1997, 158:6029-6036.
122. Weibel R.E., Neff B.J., Kuter B.J., Guess H.A., Rothenberger C.A., Fitzgerald A.J., Connor K.A., McLean A.A., Hilleman M.R., Buynak E.B. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. New England Journal of Medicine 1984, 310:1409-1415.
123. White R.J., Averner M. Humans in space. Nature 2001, 409:1115-1118.
124. Williams D.R. The biomedical challenges of space flight. Annual Review of Medicine 2003, 54:245-256.
125. Zerwekh J.E. Nutrition and renal stone disease in space. Nutrition 2002, 18:857-863.
126. Zieg G., Lack G., Harbeck R.J., Gelfand E.W., Leung D.Y. In vivo effects of glucocorticoids on IgE production. J. Allergy Clin. Immunol. 1994, 94:222-230.